K/BxN serum transfer model
Urokinase type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models
12
Matrix Metalloproteinase MMP 9 Promotes K/BxN Serum Induced Arthritis in Mice
7
Disease severity in K/BxN serum transfer induced arthritis is not affected by IL 33 deficiency
14
The caspase 8/RIPK3 signaling axis in antigen presenting cells controls the inflammatory arthritic response
16
CD55 deposited on synovial collagen fibers protects from immune complex mediated arthritis
12
Collagenase 3 (MMP 13) deficiency protects C57BL/6 mice from antibody induced arthritis
7
Autoantibody mediated arthritis in the absence of C3 and activating Fcγ receptors: C5 is activated by the coagulation cascade
8
Reduced Locomotor Activity Correlates with Increased Severity of Arthritis in a Mouse Model of Antibody Induced Arthritis
7
PAD4 is not essential for disease in the K/BxN murine autoantibody mediated model of arthritis
10
IL 17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis
10
Matrix metalloproteinase 8 deficiency increases joint inflammation and bone erosion in the K/BxN serum transfer arthritis model
12
The MHC class I–like Fc receptor promotes humorally mediated autoimmune disease
7
ApoE deficiency exacerbates the development and sustainment of a semi chronic K/BxN serum transfer induced arthritis model
12
Pro apoptotic Bid is required for the resolution of the effector phase of inflammatory arthritis
10
The impact of age and gut microbiota on Th17 and Tfh cells in K/BxN autoimmune arthritis
13
Characterisation of fibroblast-like synoviocytes from a murine model of joint inflammation
16
Characterisation of fibroblast like synoviocytes from a murine model of joint inflammation
15
Influenza Virus Hemagglutinin Stalk Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
13
Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trials
8
Effect of malaria on: Serum K, Serum Na and Blood urea- Sudan
12